This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of molecules targeting central nervous system disorders, including anxiety and depression. Its triazolopyrazine structure is valuable in designing compounds that interact with specific neurotransmitter receptors, enhancing therapeutic efficacy. Additionally, it is explored in oncology research for developing inhibitors that target abnormal cellular signaling pathways in cancer. Its chemical properties make it a versatile building block in medicinal chemistry, aiding in the discovery of new treatments for various diseases.